US 8,691,871 B2Granted

Methods of treating mixed dyslipidemia

AssigneeAmarin Pharmaceuticals Ireland Limited

InventorsIan Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Mehar Manku

Life of this patent

Estimating the term…

Abstract

The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.

Claims14

Dependent claims

A method of treating mixed dyslipidemia in a subject in the thereof comprising, administering to the subject daily a statin and about 4 g of ethyl eicosapentaenoate effective to reduce fasting triglycerides and LDL-C relative to subjects having mixed dyslipidemia who are receiving a statin without said ethyl eicosapentaenoate.

Dependencies are inferred from the claim text.

Facts

Application: 13/898,447Filed 20 May 2013 · continuation
Priority: 29 Apr 2009
Published: US 2013/0005757 A126 Sep 2013
Granted: 8 Apr 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification30 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61K 9/127
Dispersions; Emulsions: synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds

Family

Application61/173,759Us provisional application · filed 29 Apr 2009
PCT/US2010/032948Parent of this continuation · filed 29 Apr 2010
Application13/417,899Parent of this continuation · filed 12 Mar 2012
Application13/540,319Parent of this continuation · filed 2 Jul 2012
US 2013/0253030 A1Pre-grant publication · published 26 Sep 2013
Application13/266,085Parent of this continuation
US 11,033,523 B2Related patent
US 2012/0121698 A1Published application
US 2012/0302589 A1Published application
US 2013/0005757 A1Published application
US 8,563,608 B2Related patent
US 8,618,166 B2Related patent
US 8,691,871 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Facts

Application

13/898,447Filed 20 May 2013 · continuation

Priority

29 Apr 2009

Published

US 2013/0005757 A126 Sep 2013

Granted

8 Apr 2014

Term ends

Not estimatedThe source records don’t support an estimate.

Classification30 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61K 9/127
Dispersions; Emulsions: synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds

Family

Application61/173,759Us provisional application · filed 29 Apr 2009

PCT/US2010/032948Parent of this continuation · filed 29 Apr 2010

Application13/417,899Parent of this continuation · filed 12 Mar 2012

Application13/540,319Parent of this continuation · filed 2 Jul 2012

US 2013/0253030 A1Pre-grant publication · published 26 Sep 2013

Application13/266,085Parent of this continuation

US 11,033,523 B2Related patent

US 2012/0121698 A1Published application

US 2012/0302589 A1Published application

US 2013/0005757 A1Published application

US 8,563,608 B2Related patent

US 8,618,166 B2Related patent

US 8,691,871 B2This patent

From the US filing history. Foreign family members aren’t listed.